First National Bank Alaska Declares Special Dividend On November 17, 2022, First National Bank Alaska declared a special cash dividend of $3.20 per share, payable on December 15, 2022. Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags dividends See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google Add on Google Not now 11/18/2022 - 04:13 PM ANCHORAGE, Alaska--(BUSINESS WIRE)-- At the Board of Directors Meeting held November 17, 2022, a special cash dividend of $3.20 per share was declared, payable on December 15, 2022, to shareholders of record as of December 1, 2022. View source version on businesswire.com: https://www.businesswire.com/news/home/20221118005564/en/ Cheri Gillian Secretary to the Board of Directors 907-777-3409 FNBAlaska.com Source: First National Bank Alaska
$GRML Top Gainer Greenland Mines Applauds Historic U.S.-Denmark-Greenland Security Agreement, Reinforcing Greenland’s Strategic Importance to the United States Sep 18, 2026 +58.60%
$REFR Top Loser Research Frontiers Welcomes Gauzy’s Court-Approved Restructuring and the Restart of SPD-Smart Light Control Film Production Sep 18, 2026 -22.97%
$XFLT Related XAI Floating Rate & Alternative Income Trust Announces Commencement of Tender Offer Sep 18, 2026
$MTB Related M&T Bank Corporation Announces Third Quarter 2026 Earnings Release and Conference Call Sep 18, 2026 conferences
$CLSK Related CleanSpark, Inc. Announces Pricing of $2.276 Billion of Senior Secured Notes Sep 18, 2026
$HOMB Related Home BancShares, Inc. Announces Recognition in Forbes Top-Performing Banks and Bank Director RankingBanking Sep 18, 2026
$AREB Related Fly Rebel Fly: American Rebel Light Beer Welcomes NFL Philadelphia Eagles Fans to Nashville for a Two-Day Music City Pregame Celebration Sep 19, 2026
$AREB Trending Four-Time World Champion and True "American Rebel" Matt Hagan Carries the No. 1 Seed into the Countdown as TSR's Championship Chase Takes Center Stage This Weekend Sep 18, 2026
$KEYS Related Keysight to Demonstrate End-to-End Solutions for Scaling AI Infrastructure at ECOC 2026 Sep 20, 2026 AI
$CUE Related Cue Biopharma Announces Positive Topline Results from CUE-221 Phase 2 Study in Chronic Spontaneous Urticaria Sep 20, 2026 clinical trial